CHA
AMGN icon

Carmichael Hill & Associates’s Amgen AMGN Stock Holding History

Carmichael Hill & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-500
Closed -$115K – 759
2020
Q4 		$115K Hold
500
– – 0.07% 204
2020
Q3 		$127K Hold
500
– – 0.08% 182
2020
Q2 		$118K Hold
500
– – 0.09% 176
2020
Q1 		$101K Hold
500
– – 0.09% 172
2019
Q4 		$121K Buy
+500
New +$110K 0.09% 178

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Carmichael Hill & Associates's AMGN Position: Q3 2024 in Review

Carmichael Hill & Associates increased its Amgen (AMGN) stake by 15% in Q3 2024, buying an estimated $29.8K and bringing the position to 693 shares worth $223K. The position accounts for 0.08% of the portfolio, ranked #174.

Carmichael Hill & Associates first reported a position in AMGN in Q4 2017 and has held it in 28 quarters since. The position peaked at $300K in Q3 2018. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Carmichael Hill & Associates held 693 shares of Amgen worth $223K as of Q3 2024.
  • Carmichael Hill & Associates bought 91 Amgen shares in Q3 2024, an estimated $29.8K.
  • Amgen made up 0.08% of Carmichael Hill & Associates's portfolio in Q3 2024, its #174 holding.
  • Carmichael Hill & Associates first reported a position in Amgen in Q4 2017 and has held it in 28 quarters since.
  • Carmichael Hill & Associates's Amgen position peaked at $300K in Q3 2018.
  • 2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.